Gujarat Health & Family Welfare Department Medical Reagents & Calibrators Tender Gujarat 2026 ISO/IS 550‑like Specifications

Tender Overview

The Gujarat Health & Family Welfare Department seeks procurement of a broad range of medical reagents, reference sera, calibrators, immunohistochemistry (IHC) kits, and clinical chemistry materials (including dengue ELISA, SGOT/ALP kits) for state clinical laboratories. Estimated value and EMD are not disclosed. The scope includes multiple items spanning injectables, IHC reagents, ordering laboratories, and reference strains (ATCC) for routine clinical chemistry and serology. The contract language allows a 25% quantity variation with potential extension at contracted rates, and delivery timing ties to the last delivery order date. Unique bid conditions emphasize advance product samples and non-returnable trial samples. Location context: Gujarat state, under the Health & Family Welfare Department. The schedule requires consistent supplier capability, and bidders must align with the single-supplier per schedule rule after qualification.

Technical Specifications & Requirements

• No BOQ items are listed; however, the tender encompasses a wide spectrum including: Inj. Levosulpiride 25 mg, Inj. Heparin Lock Flush 10 IU/10 ml vial, IHC reagents for MAL, OSEOCALCIN, OSTEONECTIN, SMMHC, Multicalibrator Seras for clinical chemistry assays (Normal/Pathological levels), ATCC reference strains (Candida albicans, Corynebacterium diphtheriae, E. coli, Pseudomonas aeruginosa, Staphylococcus aureus, Enterococcus faecalis), Serum SGOT/ALP estimation kits, and Dengue IgM ELISA.
• Key bid conditions include advance product samples due within 5 days (120 hrs) post bid end date; samples are non-returnable and provided at no cost; submission must be from the same company for final order if qualified; Schedule No. 18-20 samples required; Schedule No. 4-7 samples if specifications differ.
• The Purchaser reserves up to 25% quantity variation during contract; delivery period adjustments are calculated as ((additional quantity/original quantity) × original delivery period) with a minimum of 30 days.
• Ensure compliance with supplier evaluation by HOD/Medical Superintendent; late/sample non-acceptance disqualifies the bidder.

Terms, Conditions & Eligibility

• EMD amount and exact value are not disclosed; bidders must comply with option clauses allowing quantity increase up to 25% during and after the contract.
• Advance samples within 5 days post bid end date; non-returnable if not accepted; final order requires same company product with no substitution.
• Acceptance of samples is at the discretion of the HOD of Department & Medical Superintendent; non-acceptance triggers re-evaluation restrictions.
• Delivery schedule is tied to the last date of the original delivery order; extended delivery time follows the option clause with the minimum 30 days rule.
• Submit required product documentation and OEM authorizations (as applicable) with bids; adhere to terms for sample submission and evaluation.